(Q38213800)

31 August 2017

title

Positron emission tomography diagnostic imaging in multidrug-resistant hepatocellular carcinoma: focus on 2-deoxy-2-(18F)Fluoro-D-Glucose (English)

1 reference

31 August 2017

main subject

multiple drug resistance

1 reference

inferred from title

hepatocellular carcinoma

1 reference

positron emission tomography

inferred from title

1 reference

Mónica Mendes

2

0 references

Ana Margarida Abrantes

object named as

Ana M Abrantes

series ordinal

3

0 references

Maria Filomena Botelho

object named as

Maria F Botelho

series ordinal

5

0 references

José G. Tralhão

series ordinal

4

object named as

José G Tralhão

1 reference

31 August 2017

Ana F Brito

1

1 reference

31 August 2017

publication date

1 October 2014

1 reference

Molecular Diagnosis and Therapy

31 August 2017

published in

1 reference

31 August 2017

volume

18

1 reference

31 August 2017

issue

5

1 reference

31 August 2017

page(s)

495-504

1 reference

https://scigraph.springernature.com/pub.10.1007/s40291-014-0106-3

31 August 2017

exact match

0 references

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

Hepatocellular carcinoma and chemotherapy: the role of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

Estimates of cancer incidence and mortality in Europe in 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

Hepatocellular carcinoma: A global view.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

Elimination of new chronic hepatitis B virus infections: results of the Alaska immunization program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

Molecular pathogenesis of human hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

Diagnosis of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

Diagnosis and Treatment of Hepatocellular Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

Drug rechallenge and treatment beyond progression--implications for drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

Hepatocellular carcinoma: epidemiology and clinical aspects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

Review article: the management of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

Multidrug resistance in cancer: role of ATP-dependent transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

Different strategies to overcome multidrug resistance in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

Multidrug resistant proteins: P-glycoprotein and lung resistance protein expression in retinoblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

Expression of multidrug resistance-associated protein 1 in hepatocellular carcinoma is associated with a more aggressive tumour phenotype and may reflect a progenitor cell origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

Multidrug resistance proteins (MRPs/ABCCs) in cancer chemotherapy and genetic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

P-glycoprotein: from genomics to mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

The medicinal chemistry of multidrug resistance (MDR) reversing drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

Mammalian ABC transporters in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

The MRP family of drug efflux pumps

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

The multidrug resistance protein family.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

Structural, mechanistic and clinical aspects of MRP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

A primer on the mechanics of P-glycoprotein the multidrug transporter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

P-glycoprotein and multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

P-glycoprotein as a drug target in the treatment of multidrug resistant cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

Expression of P-glycoprotein in hepatocellular carcinoma. A determinant of chemotherapy response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

P-glycoprotein expression in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

Expression of P-glycoprotein in hepatocellular carcinoma: a potential marker of prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

Expression of P-glycoprotein and p53 in advanced hepatocellular carcinoma treated by single agent chemotherapy: clinical correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

MDR1 gene expression in hepatocellular carcinoma and the peritumoral liver of patients with and without cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

Clinical evaluation of targeted arterial infusion of verapamil in the interventional chemotherapy of primary hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

Three decades of P-gp inhibitors: skimming through several generations and scaffolds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

Mechanisms and insights into drug resistance in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

High expression of MDR1, MRP1, and MRP3 in the hepatic progenitor cell compartment and hepatocytes in severe human liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

On the Origin of Cancer Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

Relevance of mitochondrial genetics and metabolism in cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

Energy metabolism in tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

Understanding the Warburg effect: the metabolic requirements of cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

Cancer metabolism: key players in metabolic reprogramming

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

Metabolic changes in cancer: beyond the Warburg effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

Cancer cell metabolism: Warburg and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

Why do cancers have high aerobic glycolysis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

Tumor cell metabolism imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

18F-FDG uptake in lung, breast, and colon cancers: molecular biology correlates and disease characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

Clinical applications of (18)F-FDG PET in the management of hepatobiliary and pancreatic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

Carbohydrate metabolism and the liver: actual aspects from physiology and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

GLUT1 as a therapeutic target in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

Quantitative evaluation of 2-deoxy-2[F-18]fluoro-D-glucose-positron emission tomography imaging on the woodchuck model of hepatocellular carcinoma with histological correlation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

Value of PET/CT in the management of primary hepatobiliary tumors, part 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

Positron emission tomography scanning in the evaluation of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

Diagnostic value for extrahepatic metastases of hepatocellular carcinoma in positron emission tomography/computed tomography scan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

Imaging of multidrug resistance in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

P-glycoprotein expression is associated with FDG uptake and cell differentiation in patients with untreated lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

Fluorine-18 fluorodeoxyglucose positron emission tomography predicts lymph node metastasis, P-glycoprotein expression, and recurrence after resection in mass-forming intrahepatic cholangiocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

The human KB multidrug-resistant cell line KB-C1 is hypersensitive to inhibitors of glycosylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

Factors influencing [F-18] 2-fluoro-2-deoxy-D-glucose (F-18 FDG) accumulation in melanoma cells: is FDG a substrate of multidrug resistance (MDR)?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

Pgp inhibition by UIC2 antibody can be followed in vitro by using tumor-diagnostic radiotracers, 99mTc-MIBI and 18FDG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

Imaging the function of P-glycoprotein with radiotracers: pharmacokinetics and in vivo applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

Effect of P-glycoprotein and multidrug resistance associated protein gene expression on Tc-99m MIBI imaging in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

In vivo and in vitro multitracer analyses of P-glycoprotein expression-related multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

The P-glycoprotein multidrug transporter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

Function and pathophysiological importance of ABCB4 (MDR3 P-glycoprotein).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

The bile salt export pump (BSEP) in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

The human ATP-binding cassette (ABC) transporter superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

Human ABCB6 localizes to both the outer mitochondrial membrane and the plasma membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

The ATP-binding cassette transporter ABCB6 is induced by arsenic and protects against arsenic cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

Breast cancer resistance protein (BCRP/ABCG2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

The ABCA2 transporter: intracellular roles in trafficking and metabolism of LDL-derived cholesterol and sterol-related compounds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0106-3

Establishment of hepatocellular carcinoma multidrug resistant monoclone cell line HepG2/mdr1.

21 January 2018

1 reference

12 December 2020

In vitro and in vivo tracer characteristics of an established multidrug-resistant human colon cancer cell line

1 reference

12 December 2020

Relevance of two genes in the multidrug resistance of hepatocellular carcinoma: in vivo and clinical studies.

1 reference

12 December 2020

Correlation of expression of multidrug resistance protein and messenger RNA with 99mTc-methoxyisobutyl isonitrile (MIBI) imaging in patients with hepatocellular carcinoma.

1 reference

12 December 2020

Mechanisms of multidrug resistance in cancer

1 reference

12 December 2020

P-glycoprotein expression affects 18F-fluorodeoxyglucose accumulation in hepatocellular carcinoma in vivo and in vitro.

1 reference

12 December 2020

Human hepatocellular carcinoma cell lines exhibit multidrug resistance unrelated to MRD1 gene expression

1 reference

12 December 2020

Targeted therapies for hepatocellular carcinoma

1 reference

12 December 2020

A global view of the biochemical pathways involved in the regulation of the metabolism of cancer cells

1 reference

12 December 2020

Hepatocellular carcinoma

1 reference

12 December 2020

Role of FDG-PET in the evaluation and staging of hepatocellular carcinoma with comparison of tumor size, AFP level, and histologic grade.

1 reference

12 December 2020

Cellular mechanisms of multidrug resistance of tumor cells.

1 reference

12 December 2020

Advanced hepatocellular carcinoma. Review of targeted molecular drugs.

1 reference

12 December 2020

Molecular imaging in oncology

1 reference

12 December 2020

Fluorine-18 fluorodeoxyglucose positron emission tomography predicts tumor differentiation, P-glycoprotein expression, and outcome after resection in hepatocellular carcinoma

1 reference

12 December 2020

Clinical significance of mrp gene in primary hepatocellular carcinoma

1 reference

12 December 2020

Complex Interplay between the P-Glycoprotein Multidrug Efflux Pump and the Membrane: Its Role in Modulating Protein Function

1 reference

12 December 2020

Gene expression of ABC proteins in hepatocellular carcinoma, perineoplastic tissue, and liver diseases

1 reference

12 December 2020

10.1007/S40291-014-0106-3

Identifiers

DOI

1 reference

Dimensions Publication ID

31 August 2017

1019110940

0 references

1 reference